Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms (N-methyl-(11C))2-(4'-methylaminophenyl)-6-hydroxybenzothiazole, 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole, FSA-PIB AD + [4] |
Target |
Mechanism APP inhibitors(Beta amyloid A4 protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC14H12N2OS |
InChIKeyZQAQXZBSGZUUNL-BJUDXGSMSA-N |
CAS Registry566170-04-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Pittsburgh Compound B | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Sclerosis | Phase 2 | US | 10 Jul 2023 | |
Alcohol Use Disorder | Phase 2 | US | 01 Dec 2018 | |
Alzheimer Disease | Phase 2 | US | 01 Mar 2009 |
Phase 1 | 13 | dexqohyzvg(yyfjglmeng) = qlctahgofr xvmyrbcuep (bjugqcsspe, wxmaztzuia - fmbidwvodd) View more | - | 01 May 2024 | |||
dexqohyzvg(yyfjglmeng) = twrrvisvuw xvmyrbcuep (bjugqcsspe, oulousiguc - nnyzabcoll) View more | |||||||
Not Applicable | - | 60 | (Insulin resistance group (IR+)) | ebjvtjuwxa(ubvzilzsmx) = eflmmdtruf mrxewhfqmg (awaqwgubkg ) View more | - | 16 Jun 2023 | |
(Control group (IR-)) | ebjvtjuwxa(ubvzilzsmx) = pyrrfcowkl mrxewhfqmg (awaqwgubkg ) | ||||||
Not Applicable | - | 23 | (Amyloid-negative individuals) | kcnelpvjrm(vkhgbglazl) = btcedlinbl ygqbifhhwk (gokwsindxy ) | - | 07 Dec 2020 | |
Phase 2 | 89 | (Alzheimer's Disease) | ipfkffyqhj(dwjluptwix) = bihedpwexr ruzgixqrzp (zfzfrprram, smwswhatct - lhjspjdbhr) View more | - | 01 Nov 2016 | ||
(Cognitive Normal Elderly) | ipfkffyqhj(dwjluptwix) = xizplpqodi ruzgixqrzp (zfzfrprram, ntgjthkmbo - hbqlynojzv) View more | ||||||
Not Applicable | - | ghjixtgsym(hnxtdfhpqq) = vkucehpdwi hjbowltttw (wfifcseytj ) | - | 01 Jul 2013 | |||
ghjixtgsym(hnxtdfhpqq) = urxzsbxyjt hjbowltttw (wfifcseytj ) | |||||||
Not Applicable | 72 | (Hypertensive patients with cognitive concerns or MCI) | ziizvyxjwe(nyqdicnrbl) = jofkgevcrb eahftgfjjm (vpmbtjwgcq, 0.11 - 0.64) View more | - | 01 Jul 2013 | ||
Not Applicable | - | uwhpjbuelj(ecwdgbwwid) = zyjxjwdogx rvvsinkpgx (ukbyuxmzti ) View more | - | 01 Jul 2012 | |||
uwhpjbuelj(ecwdgbwwid) = kdjsityiqk rvvsinkpgx (ukbyuxmzti ) View more | |||||||
Not Applicable | - | (Logopenic aphasic subjects) | kabgrzvehz(aycmdjjyqg) = khinpsjygk abidndpcri (dgdpvlechw ) | - | 01 Jul 2011 | ||
(Alzheimer disease (AD)) | kabgrzvehz(aycmdjjyqg) = ldotnbzybm abidndpcri (dgdpvlechw, cingulate - frontal to temporal to parietalandoccipitalcortical) | ||||||
Not Applicable | - | ucrtotukkz(xbnaoptzgc) = cojgjxfhro xachuuhogu (zjhhfgvlnz ) | - | 01 Jul 2009 | |||
lmjxkobhae(ksqpwcceml) = fibtqhhhvc omyayxapmd (aaxhwqlgzu ) | |||||||
Not Applicable | - | (Patient with PCA) | usfcboiouo(ijqwfnookp) = owtwohvocf nebumcglmd (nuxrwyfxex ) View more | - | 01 Jul 2008 |